Vitiligo Update

Vitiligo is an acquired dyschromia of the skin in which there is a loss of epidermal
melanocytes. The prevalence of vitiligo is approximately 1% in the United States and
0.1-2% worldwide. The exact pathogenesis of vitiligo remains elusive and is likely multifactorial.
After completing this update, participants should be able to discuss the epidemiology
of vitiligo and summarize the proposed mechanisms for development of this
disease. In addition, they should be able to discuss physical findings, approach to the
patient, and some of the therapeutic modalities for this disorder.
Semin Cutan Med Surg 28:86-92 © 2009 Elsevier Inc. All rights reserved.

Purchase this article:

PURCHASE FOR $25

For unlimited access to all issues and articles:

If you do not subscribe to Seminars in Cutaneous Medicine and Surgery, you may purchase instant access for your personal use. Terms and conditions will apply (see Copyright & Terms of Use). If you need assistance, contact Susan Hite (scmsjournal@frontlinemedcom.com).